Bone marrow transplantation for severe aplastic anemia: Has outcome improved?

Blood

Volumn 90, Issue 2, 1997, Pages 858-864

  Passweg, Jakob R ^b   Socié, Gérard ^b   Hinterberger, Wolfgang ^b   Bacigalupo, Andrea ^b   Biggs, James C ^b   Camitta, Bruce M ^b   Champlin, Richard E ^b   Gale, Robert Peter ^b   Gluckman, Eliane ^b   Gordon Smith, Edward C ^b   Hows, Jill M ^b   Klein, John P ^b   Nugent, Melodee L ^b   Pasquini, Ricardo ^b   Rowlings, Philip A ^b   Speck, Bruno ^b   Tichelli, André ^b   Zhang, Mei Jie ^b   Horowitz, Mary M ^a   Bortin, Mortimer M ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INTERSTITIAL PNEUMONIA; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SURVIVAL; TREATMENT OUTCOME;

AGE FACTORS; ANEMIA, APLASTIC; BONE MARROW TRANSPLANTATION; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSION; LUNG DISEASES, INTERSTITIAL; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0030877514     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Storb R, Thomas ED, Buckner CD, Clift RA, Johnson FL, Fefer A, Glucksberg H, Giblett ER, Lerner KG, Neiman P: Allogeneic marrow grafting for treatment of aplastic anemia. Blood 43:157, 1974
2. Young NS, Barrett AJ: The treatment of severe acquired aplastic anemia. Blood 85:3367, 1995
3. Santos GW, Sensenbrenner LL, Anderson PN, Burke PJ, Klein DL, Slavin RE, Schacter B, Bargaonhan DS: HLA-identical marrow transplantation in aplastic anemia, acute leukemia, and lymphosarcoma employing cyclophosphamide. Transplant Proc 8:607, 1976
4. Bortin MM, Gale RP, Rimm AA: Allogeneic bone marrow transplantation for 144 patients with severe aplastic anemia. JAMA 245:1132, 1981
5. Camitta BM, Thomas ED, Nathan DG, Gale RP, Kopecky KJ, Rappeport JM, Santos G, Gordon-Smith EC, Storb R: A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 53:504, 1979
6. Hows JM, Palmer S, Gordon-Smith EC: Use of cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anemia. Transplantation 33:382, 1982
7. Storb R, Doney KC, Thomas ED, Appelbaum F, Buckner CD, Clift RA, Deeg HJ, Goodell W, Hackman R, Hansen JA, Sanders J, Sullivan K, Weiden PL, Witherspoon RP: Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood 59:236, 1982
8. Feig SA, Champlin R, Arenson E, Yale C, Ho W, Tesler A, Gale RP: Improved survival following bone marrow transplantation for aplastic anemia. Br J Haematol 54:509, 1983
9. Ramsay WKC, Kim TH, Nesbit ME, Krivit W, Coccia P, Levitt S, Woods W, Kersey JH: Total lymphoid irradiation and cyclophosphamide as preparation for bone marrow transplantation in severe aplastic anemia. Blood 55:344, 1980
10. Bayever E, Champlin R, Ho W, Lenarsky C, Storch S, Ladish J: Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia. J Pediatr 105:920, 1984
11. Storb R, Deeg HJ, Farewell V, Doney K, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Hansen J, Hill R, Longton G, Lum L, Martin P, McGuffin R, Sanders J, Singer J, Stewart P, Sullivan K, Witherspoon R, Thomas ED: Marrow transplantation for severe aplastic anemia: Methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute-graft-versus host disease. Blood 69:119, 1986
12. Gluckman E, Devergie A, Meletis J, Traineau R, Vilmer E, Lehn P, Keable H, Bourhis JH, Varrin F: Bone marrow transplantation for severe aplastic anemia: Report of 97 consecutive patients. Bone Marrow Transplant 2:101, 1987
13. Anasetti C, Storb R, Longton G, Witherspoon R, Doney K, Sullivan KM, Thomas ED: Donor buffy coat cell infusion after marrow transplantation for aplastic anemia. Blood 72:1099, 1988
14. Locasciulli A, van't Veer L, Bacigalupo A, Hows J, Van Lint MT, Gluckman E, Nissen C, McCann S, Vossen J, Schrezenmeier A, Hinterberger W, Marin A: Treatment with marrow transplantation or immunosuppression of childhood acquired severe aplastic anemia: A report from the EBMT SAA Working Party. Bone Marrow Transplant 6:211, 1990
15. Paquette RL, Tebyani N, Frane M, Ireland P, Ho WG, Champlin RE, Nimer SD: Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: Comparison with bone marrow transplantation. Blood 85:283, 1995
16. Storb R, Etzioni R, Anasetti C, Appelbaum FR, Buckner CD, Bensinger W, Bryant E, Clift R, Deeg HJ, Doney K, Flowers M, Hansen J, Martin P, Pepe M, Sale G, Sanders J, Singer J, Sullivan KM, Thomas ED, Witherspoon RD: Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 84:941, 1994
17. Marsh JC, Socié G, Schrezenmeier H, Tichelli A, Gluckman E, Ljungman P, McCann SR, Raghavachar A, Marin P, Hows JM: Haemopoietic growth factors in aplastic anaemia: A cautionary note. European Bone Marrow Transplant Working Party for Severe Aplastic Anaemia. Lancet 344:172, 1994
18. Storb R, Longton G, Anasetti C, Appelbaum FR, Beatty P, Bensinger W, Crawford S, Deeg HJ, Doney K, Fefer A, Hansen J, Loughran T, Martin P, Pepe M, Petersen FB, Sanders JE, Singer J, Stewart P, Sullivan KM, Thomas ED, Witherspoon RP. Changing trends in marrow transplantation for aplastic anemia. Bone Marrow Transplant 10:45, 1992 (suppl 1)
19. McCann SR, Bacigalupo A, Gluckman E, Hinterberger W, Hows J, Ljungman P, Marin P, Nissen C, van't Veer Kerthof E, Raghavachar A, Socié G, Frickhofen N, Locasciulli A, Schrezenmeier H: Graft rejection and second bone marrow transplants for acquired aplastic anaemia: A report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group. Bone Marrow Transplant 13:233, 1994
20. Champlin RE, Horowitz MM, van Bekkum DW, Camilla BM, Elfenbein GE, Gale RP, Gluckman E, Good RA, Rimm AA, Rozman C, Speck B, Bortin MM: Graft failure following bone marrow transplantation for severe aplastic anemia: Risk factors and treatment results. Blood 73:606, 1989
21. Atkinson K, Horowitz MM, Gale RP, Van Bekkum DW, Gluckman E, Good RA, Jacobsen N, Kolb HJ, Rimm AA, Ringdén O, Rozman C, Sobocinski KA, Zwaan FE, Bortin MM: Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 75:2459, 1990
22. Gluckman E, Horowitz MM, Hows JM, Bacigalupo A, Biggs JC, Champlin RE, Camitta BM, Gale RP, Gordon-Smith EC, Marmont AM, Masaoka T, Ramsay NKC, Rimm AA, Rozman C, Sobocinski KA, Speck B, Bortin MM: Bone marrow transplantation for severe aplastic anemia: Influence of conditioning regimens on outcome. Blood 79:269, 1992
23. Castro-Malaspina H, Childs B, Laver J, Shank B, Brochstein J, Gillio A, Flomenberg N, Young J, Boulad F, Black P, Kernan N, Fuchs Z, O'Reilly R: Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anemia. Int J Radiat Oncol Biol Phys 29:847, 1994
24. Gluckman E, Socié G, Devergie A, Bourdeau-Esperou H, Traineau R, Cosset JM: Bone marrow transplantation in 107 patients with severe aplastic anemia using cyclophosphamide and thoraco-abdominal irradiation for conditioning: Long-term follow-up. Blood 78:2451, 1991
25. May WS, Sensenbrenner LL, Burns WH, Ambinder R, Carroll MP, Griffin CA, Jones RJ, Miller CB, Mellits ED, Vogelsang GB, Wagner JE, Wingard JR, Yeager AM, Santos GW: BMT for severe aplastic anemia using cyclosporine. Bone Marrow Transplant 11:459, 1993
26. Storb R, Deeg HJ, Pepe M, Doney K, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Hansen J: Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: Long-term follow-up of a controlled trial. Br J Haematol 72:567, 1989
27. Sullivan KM, Meyers J, Petersen FB, Bowden R, Counts GC, Banaji M, Schubert M, Clark J, Clift RA, Appelbaum FR, Bensinger WI, Stewart P, Storb R, Thomas ED, Buckner CD: Supportive care of the marrow transplant recipient: the Seattle Experience. Haematol Bluttransfus 33:539, 1990
28. Poe SS, Larson E, McGuire D, Krumm S: A national survey of infection prevention practices on bone marrow transplant units. Oncol Nurs Forum 21:1687, 1994
29. Prentice HG, Gluckman E, Powles RL, Ljungman P, Milpied N, Fernandez, Ranada JM, Mandelli F, Kho P, Kennedy L, Bell AR: Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. Lancet 343:749, 1994
30. Wingard JR: Viral infections in leukemia and bone marrow transplant patients. Leuk Lymphoma 11:115, 1993 (suppl 2)
31. Ljungman P, De Bock R, Cordonnier C, Einsele H, Engelhard D, Grundy J, Locasciulli A, Reusser P, Ribaud P: Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: A report from the Working Party for Infectious Diseases of the EBMT. Bone Marrow Transplant 12:399, 1993
32. Winston DJ: Prophylaxis and treatment of infection in the bone marrow transplant recipient. Curr Clin Top Infect Dis 13:293, 1993
33. Hoyle C, Goldman JM: Life-threatening infections occurring more than 3 months after BMT. 18 UK Bone Marrow Transplant Teams. Bone Marrow Transplant 14:247, 1994
34. Storb R, Prentice RL, Buckner CD, Clift R, Appelbaum F, Deeg HJ, Doney K, Hansen J, Mason M, Sanders JE, Singer J, Sullivan KM, Witherspoon RP, Thomas ED: Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow graft from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med 308:302, 1983
35. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED: Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18:295, 1974
36. Weiner RS, Horowitz MM, Gale RP, Dicke KA, van Bekkum DW, Masaoka T, Ramsay NKC, Rimm AA, Rozman C, Bortin MM: Risk factors for interstitial pneumonia following bone marrow transplantation for severe aplastic anaemia. Br J Haematol 71:535, 1989
37. Weiner RS, Bortin MM, Gale RP, Gluckman E, Kay HE, Kolb HJ, Hartz AJ, Rimm AA: Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med 104:168, 1986
38. Cox DR: Regression models and life tables. J Roy Stat Soc B 34:187, 1972
39. Smith DG, Clemins J, Crede W, Harvey M, Gracely EJ: Impact of multiple comparisons in randomized clinical trials. Am J Med 83:545, 1987
40. Storb R: Bone marrow transplantation for aplastic anemia. Cell Transplant 2:365, 1994
41. Bacigalupo A: Severe Aplastic Anaemia Working Party, in EBMT Working Parties Reports. Harrowgate, UK, European Group for Bone Marrow Transplantation, 1994, p 49
42. Socié G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, McCann SR, Frickhofen N, Van't Veer-Korthof E, Gluckman E: Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med 329:1152, 1993
43. Pierga JY, Socié G, Gluckman E, Devergie A, Henry-Amar M, Bridier A, Girinsky T, Nguyen J, Cosset JM: Secondary solid malignant tumors occurring after bone marrow transplantation for severe aplastic anemia given thoraco-abdominal irradiation. Radiother Oncol 30:55, 1994
44. Siadak MF, Kopecky K, Sullivan KM: Reduction in transplant-related complications in patients given intravenous immune globulin after allogeneic marrow transplantation. Clin Exp Immunol 97:53, 1994 (suppl 1)
45. Sullivan KM, Kopecky KJ, Jocom J, Fisher L, Buckner CD, Meyers JD, Counts GW, Bowden RA, Peterson FB, Witherspoon RP, Budinger MD, Schwartz RS, Appelbaum FR, Clift RA, Hansen JA, Sanders JE, Thomas ED, Storb R: Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med 323:705, 1990
46. Bordin JO, Heddle NM, Blajchman MA: Biologic effects of leukocytes present in transfused cellular blood products. Blood 83:1703, 1994